GlaxoSmithKline, Research Triangle Park, Durham, NC, USA.
GlaxoSmithKline, Mississauga, ON, Canada.
Can Respir J. 2017;2017:8184915. doi: 10.1155/2017/8184915. Epub 2017 Jun 20.
Chronic obstructive pulmonary disease (COPD) prevalence in Canada has risen over time. COPD-related exacerbations contribute to the increased health care utilization (HCU) in this population. This study investigated the impact of exacerbations on COPD-related HCU.
This retrospective observational cohort study used patient data from the Québec provincial health insurance databases. Eligible patients with a new HCU claim with a diagnostic billing for COPD during 2001-2010 were followed until March 31, 2011. Exacerbation rates and time to first exacerbation were assessed. Unadjusted analyses and multivariable models compared the rate of HCU by exacerbation classification (any [moderate/severe], moderate, or severe).
The exacerbation event rate in patients with an exacerbation was 34.3 events/100 patient-years (22.7 for moderate exacerbations and 11.6 for severe exacerbations). Median time to first exacerbation of any classification was 37 months. In unadjusted analyses, COPD-related HCU significantly increased with exacerbation severity. In the multivariable, HCU rates were significantly higher after exacerbation versus before exacerbation ( < 0.01) for patients with an exacerbation or moderate exacerbations. For severe exacerbations, general practitioner, respiratory specialist, emergency room, and hospital visits were significantly higher after exacerbation versus before exacerbation ( < 0.001).
Exacerbations were associated with increased HCU, which was more pronounced for patients with severe exacerbations. Interventions to reduce the risk of exacerbations in patients with COPD may reduce disease burden.
加拿大的慢性阻塞性肺疾病(COPD)患病率呈上升趋势。COPD 相关加重会导致该人群的医疗保健利用率(HCU)增加。本研究调查了加重对 COPD 相关 HCU 的影响。
本回顾性观察队列研究使用了魁北克省健康保险数据库中的患者数据。符合条件的患者在 2001 年至 2010 年期间因新的 HCU 索赔而获得 COPD 的诊断性计费,可随访至 2011 年 3 月 31 日。评估了加重的发生率和首次加重的时间。在未调整分析和多变量模型中,根据加重分类(任何[中度/重度]、中度或重度)比较了 HCU 的发生率。
加重患者的加重事件发生率为 34.3 例/100 患者年(中度加重 22.7 例,重度加重 11.6 例)。首次任何分类加重的中位时间为 37 个月。在未调整分析中,随着加重严重程度的增加,COPD 相关 HCU 显著增加。在多变量分析中,与加重前相比,加重后 HCU 率显著升高(<0.01),无论是加重患者还是中度加重患者。对于重度加重患者,与加重前相比,全科医生、呼吸科专家、急诊室和住院就诊的就诊率显著升高(<0.001)。
加重与 HCU 增加相关,对于重度加重患者更为明显。干预措施可降低 COPD 患者加重的风险,从而降低疾病负担。